Impact of preoperative sarcopenia on morbidity in gastric cancer surgery.

Authors

null

Tsutomu Sato

Department of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama-shi, Japan

Tsutomu Sato , Toru Aoyama , Tsutomu Hayashi , Haruhiko Cho , Taiichi Kawabe , Hirohito Fujikawa , Takashi Ogata , Takanobu Yamada , Shinichi Hasegawa , Takashi Oshima , Yasushi Rino , Munetaka Masuda , Takaki Yoshikawa

Organizations

Department of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama-shi, Japan, Department of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama, Japan, Kanagawa Cancer Center, Yokohama, Japan, Department of Surgery, Yokohama City University, Yokohama, Japan, Gastroenterological Center, Yokohama City University, Yokohama, Japan

Research Funding

No funding sources reported

Background: Skeletal muscle depletion, known as sarcopenia, is characterized by decrease in muscle mass and function. Recent reports demonstrated that sarcopenia was a significant risk factor for complications in colorectal cancer surgery. This study aimed to evaluate impact of preoperative sarcopenia on morbidity in gastric cancer surgery. Methods: Between May 2011 and June 2013, 293 consecutive primary gastric cancer patients who underwent curative surgery were retrospectively examined. All patients received the same perioperative care of enhanced recovery after surgery program. Preoperative skeletal muscle mass was evaluated by bioelectrical impedance analysis and was expressed as skeletal muscle index or SMI (muscle mass/height2) by adjusting absolute muscle mass with height. Preoperative muscle function was measured by hand grip strength (HGS). Each cutoff value was determined as the gender-specific lowest 20% of the distribution of each measurement. Grade 2 or higher morbidity, evaluated by Clavien-Dindo classification, was picked-up from the patient record. Risk factor for morbidity was examined by uni- and multi-variate analyses. Results: Median age (range) was 68 years (37-85 years). Male to female ratio was 192:101. Operative procedure was 122 total, 169 distal, and 2 proximal gastrectomy. Lymphadenectomy was 162 D1+ and 131 D2 including 53 splenectomy. Pathological stage was I in 149, II in 39, III in 91, and IV in 14 patients. Morbidity included 7 pancreatic leakage, 12 anastomotic leakage, 4 intra-abdominal abscess, and others. In total, morbidity was observed in 39 patients (13.3%); 21 in grade 2, 16 in grade 3a, 1 in grade 3b, and 1 in grade 4. No mortality was observed. Univariate analysis showed that male, total gastrectomy, splenectomy, and low HGS were significant risk factor for morbidity. Low SMI was not a risk factor. By multi-variate analysis, low HGS(HR 2.457, p=0.029), male(HR 2.610, p=0.038)and total gastrectomy(HR 2.747, p=0.027)remained significant. Conclusions: Low hand grip strength was one of significant risk factor for morbidity in gastric cancer surgery. Hand grip strength as a surgical risk has a value to be examined in the future prospective studies.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2014 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

General Poster Session A: Cancers of the Esophagus and Stomach

Track

Cancers of the Esophagus and Stomach

Sub Track

Prevention, Diagnosis, and Screening

Citation

J Clin Oncol 32, 2014 (suppl 3; abstr 40)

DOI

10.1200/jco.2014.32.3_suppl.40

Abstract #

40

Poster Bd #

B14

Abstract Disclosures

Similar Abstracts

First Author: Lin Wang

Abstract

2016 Gastrointestinal Cancers Symposium

Impact of preoperative sarcopenia on recurrecnce in gastric cancer surgery.

First Author: Tsutomu Sato

Abstract

2024 ASCO Gastrointestinal Cancers Symposium

Prevalence of modifiable risk factors of Hispanic adult patients admitted with gastric cancer in the US.

First Author: Alejandro Nieto Dominguez

Abstract

2024 ASCO Gastrointestinal Cancers Symposium

Clinical risk factors for splenic hilar nodal metastasis in remnant gastric cancer after distal gastrectomy.

First Author: Ryota Sakon